Stomahesive is used in situations involving certain distressing symptoms. It is commonly used to help manage symptoms related to inflammatory or irritative states around the stoma.

---

Relief for Irritated Skin and Stability

This hydrocolloid barrier provides support that helps ease the overall symptom burden associated with conditions like irritant contact dermatitis, minor skin erosions, and maceration. Applied across domains where additional symptomatic support is needed, it is a key component for managing symptoms that interfere with daily functioning.

Stomahesive is applied across domains where additional symptomatic support is needed, helping ease symptoms related to physical discomfort in raw, weeping, or reddened tissue. Furthermore, it is relevant in contexts marked by increased discomfort or tension, addressing symptoms such as uneven skin surfaces or depressed areas, which may create noticeable functional strain. This supports general well-being during symptomatic phases and contributes to improved day-to-day comfort.

“Applied in situations requiring short-term symptomatic support, this product is used for managing symptom clusters that may become intense or disruptive associated with persistent wetness.”

---

Quick Fact: Support for Peristomal Skin Complications

Stomahesive is commonly used to help manage symptoms of skin redness, pain, maceration, and seal instability, contributing to improved comfort during symptomatic periods.

Who Can and Cannot Use Stomahesive Paste?

Stomahesive Paste is regulated as a medical device (skin barrier accessory), and its eligibility profile is primarily based on local factors rather than systemic health.

Official Eligibility Constraints

Constraint Category	Official Regulatory Statement
Absolute Contraindication	Individuals with a known hypersensitivity or allergy to the paste or any of its ingredients.
Application Restriction	Must NOT be applied into an open wound or skin ulcer; the paste is for external use only on the skin surface.

---

Systemic Population Eligibility

The regulatory labeling for Stomahesive Paste does not impose restrictions related to systemic health. Use is permitted across all applicable groups:

• Age Groups: No specific restrictions are documented for use in infants, children, adolescents, adults, or older adults.
• Pregnancy and Lactation: No official warnings or restrictions are documented for use during pregnancy or breastfeeding.
• Comorbidities: No restrictions are documented concerning underlying systemic conditions such as renal or hepatic impairment.

Eligibility is defined by the need for peristomal skin protection and the absence of a known allergy to the product.

Interactions with other medicines and products

Stomahesive Paste and Powder are hydrocolloid-based products intended for topical use in ostomy care. As a medical device/accessory, its components—such as pectin, sodium carboxymethyl cellulose, and gelatin—are not systemically absorbed. Consequently, Stomahesive does not have documented drug-drug interactions related to systemic pharmacology, such as metabolic pathways (e.g., CYP enzymes), drug transporters, or pharmacodynamic effects described in regulatory labeling for medicines.

Its official interaction profile is limited to physical and chemical incompatibilities that affect its intended function or safety.

---

Official Interaction Constraints

Interaction Type	Constraint Described in Regulatory Documentation
Physical Adhesion Incompatibility	The product's seal and adhesive function can be compromised by the presence of oil-based products, excessive moisture, or topical residues on the skin prior to application.
Flammability Hazard (Paste Only)	Stomahesive Paste contains a flammable solvent. Regulatory safety documents mandate that the paste must be kept away from heat, sparks, open flames, and hot surfaces until the solvent has completely dried/evaporated.

---

This structure reflects the regulatory focus on ensuring the proper physical function of the barrier and mitigating the flammability risk associated with the paste's formulation. No systemic drug interaction warnings are applicable or officially documented for this product.

The mechanism of Stomahesive is defined by its physico-chemical and biomechanical actions, operating strictly at the surface of the skin. It does not exert a pharmacological effect on internal biological targets. The highly hydrophilic ingredients, primarily Carmellose, rapidly target and absorb peristomal effluent and moisture. This absorption initiates immediate gelation and viscosity increase, resulting in the creation of an occlusive barrier that adheres to the Stratum Corneum. This physical separation is the essential mechanistic step that isolates the sensitive epidermal tissue from corrosive chemical and enzymatic irritants.

By establishing this physical shield, the barrier drastically reduces Transepidermal Water Loss (TEWL), which facilitates the retention of hydration and the structural integrity of the Epidermal Barrier Function. The maintained moisture and stabilization of the local pH environment supports tissue homeostasis. The synergistic combination of multiple components ensures the material is both highly absorbent and conformable. This allows the matrix to fill minor skin irregularities and maintain a continuous, gap-free seal, which is essential for preserving the integrity of the primary occlusive mechanism.

How to Use Stomahesive

Instructions for Stomahesive use are structured around the product's function as a protective barrier and filler applied to the skin around a stoma. This administration is topical and occurs whenever a new skin barrier/pouching system is applied.

Administration Protocol

Preparation is mandatory before application. The peristomal skin must be cleansed with mild soap free of oils and creams, rinsed well with clear water, and dried thoroughly.

Product Form	Application Instructions	Frequency & Schedule
Paste	Apply a thin ring or bead on the back of the skin barrier, or directly to the skin to fill depressions. Do not spread the paste on the barrier. Allow one minute to set before applying.	Applied when changing the skin barrier. Easily removed after 48 hours.
Powder	Apply a light dusting over affected moist or weeping areas. Brush away any excess powder that could interfere with adhesion.	Used with each skin barrier change or as needed. Discontinue once the weeping area has healed.

Application and Removal

To ensure a seal, the skin barrier must be centered over the stoma, then pressed down firmly for 30 to 60 seconds. When removing the system, the skin must be supported while the barrier is gently peeled away. Residual paste can be removed with warm water, but complete removal is not necessary prior to a new application.

Research Evidence: Overview of Studies for Stomahesive

Evidence for Management of Peristomal Skin Complications (PSCs)

Research was evaluated in contexts involving peristomal irritant contact dermatitis, maceration (skin wetness), and skin excoriation. These are conditions linked to inflammatory or irritative states caused by exposure to stomal output. The evidence base includes broad Systematic Reviews that assess the general hydrocolloid technology, alongside specific observational studies and small case series that have monitored the product's evaluation in daily care settings.

Studies explored skin symptom patterns and changes in measured outcomes, focusing on how symptoms evolved in the observed populations. Findings describe patterns observed in these studies regarding time intervals for skin symptom changes for acute damage, and research was observed in contexts involving the stability of the entire ostomy system.

Evidence for Functional Barrier Support and Symptom Relief

This area of research was studied for its physical properties, including its function as a filler for uneven skin contours, and was used in research examining outcomes related to physical discomfort. Available data includes Randomized Controlled Trials (RCTs) that have compared different types of adhesive technologies, as well as case studies focusing on individual patient experiences.

Research monitored outcomes related to patient-reported discomfort and pain experienced by ostomy users. Studies reported measurements of changes in symptom severity scores during periods of use. Comparative evidence is lacking for direct, large-scale comparisons between this specific paste/powder and other similar products on comfort endpoints.

Gaps and Uncertainties in the Existing Evidence

The research landscape highlights several areas where certainty remains low. Much of the high-level evidence focuses on the general hydrocolloid technology, rather than the specific Stomahesive formulations. Long-term effects are not fully established, as follow-up durations were limited in many studies. Evidence quality varies across studies, with many findings based on modest sample sizes or derived from observational settings rather than controlled trials. This research provides context, but does not determine whether an individual will respond similarly.

Key Studies & References Ostomy: Changing the pouch - MedlinePlus (NIH)

Common questions about Stomahesive (FAQ)

Q: Is Stomahesive considered a permanent adhesive or a temporary filler/sealant?

According to official documentation, Stomahesive is not classified as a permanent adhesive or glue. It is designed to function as a filler or caulking substance. Its primary purpose is to fill in uneven skin contours, which may help the primary ostomy barrier achieve a seal that contributes to the intended wear time.

Q: Is it normal for Stomahesive Paste to cause a temporary stinging sensation upon initial application?

Regulatory safety documents contain a warning about the Paste's formulation. Because the Paste contains alcohol, its application may cause stinging if the peristomal skin is already excoriated (scraped) or irritated. This information helps explain the presence of alcohol in the formulation.

Q: What is the distinction between Stomahesive and the Durahesive product line?

The distinction between Stomahesive and Durahesive is based on their intended functional design, as documented in official materials. Durahesive skin barriers are engineered for extended wear and are officially described for patients whose stoma output is mostly liquid. These barriers are designed to gently swell (known as 'turtlenecking') to support the seal’s integrity in the presence of liquid output.

Q: Are there any known issues with using Stomahesive while swimming or bathing in public pools?

Official product instructions emphasize the importance of applying the paste and barrier system to a clean and thoroughly dry surface to ensure proper initial adhesion. The hydrocolloid material is designed to resist breakdown when forming a seal. Official regulatory guidance, however, generally does not include explicit data on the product's performance during prolonged water exposure, such as swimming.

Q: Does Stomahesive Paste typically harden completely or remain pliable and soft after application?

The product's mechanism involves gelation and an increase in viscosity to create a protective, occlusive barrier. Official information indicates that the material is designed to be conformable. This allows the material to remain flexible and fill minor skin irregularities, which supports the creation of a continuous seal.

Q: Is there a version of Stomahesive Paste that is described as alcohol-free?

The official Stomahesive Paste formulation documented in regulatory labeling contains alcohol. There is no documented or regulated version of Stomahesive Paste that is explicitly labeled as alcohol-free in the official product information.

Q: What materials is the Stomahesive wafer or skin barrier made from?

The Stomahesive skin barrier or wafer is classified as a hydrocolloid product. This means its primary structural material is a matrix composed of high water-retaining ingredients. The core components, like those in the paste and powder, typically include substances such as Carmellose (Sodium Carboxymethyl Cellulose), Pectin, and Gelatin.

Q: How do I know if I'm using a Stomahesive or a Durahesive skin barrier?

A method used to distinguish the barriers is to refer to the official functional descriptions. Durahesive barriers are officially intended for extended wear and are often used by patients with predominantly liquid stoma output. Stomahesive is intended for patients with more formed output.

Q: Is there any evidence that Stomahesive causes skin stripping upon removal?

Official safety information does not specifically list skin stripping as an adverse reaction. Medical literature discussing peristomal complications notes that hydrocolloid barrier products are used as a strategy to help maintain skin integrity. The product's role is to help maintain the health of the skin during the routine use of adhesive systems.

Q: Is there a defined limit to how many layers of Stomahesive Powder can be used? (Factual limit, non-directive)

Official administration instructions specify that only a light dusting of Stomahesive Powder should be applied to the affected area. Official instructions indicate that excess powder should be brushed away before applying the skin barrier, as accumulation could interfere with the skin barrier’s ability to adhere properly.

The storage and disposal of Stomahesive products are defined by regulatory requirements to ensure product integrity and safety.

Storage Requirements

Product Form	Temperature Condition	Protection Constraint
Paste	Store at mathbf10 C (mathbf50 F) or Room Temperature	Keep away from heat, open flames, and ignition sources
Powder	Must meet USP Controlled Room Temperature	Store in a cool, dry, well-ventilated area

Both the paste and powder containers must be kept tightly closed [1.7], and the paste cap should be tightened securely after each use [3.6] to maintain stability. The product should also be stored away from direct sunlight [1.7] and protected against electrostatic charges [1.7].

Disposal Instructions

Disposal of both the Stomahesive product and its container must be conducted in adherence to local disposal requirements and regulations [3.6], including all regional, national, and international laws [1.7].